远程医疗公司LifeMD Inc.（纳斯达克股票代码：LFMD）今日盘前大跌25%，主要原因是公司发布的第二季度财报不及市场预期，并下调了全年业绩指引。
根据公司公布的财报，截至6月30日的第二季度，LifeMD调整后每股亏损6美分，远超分析师预期的1美分亏损。公司营收为6222万美元，同比增长22.8%，但低于市场预期的6634万美元。此外，LifeMD在本季度净亏损285万美元。这些数据显示，尽管公司收入增长，但盈利能力仍面临挑战。
更令投资者担忧的是，LifeMD大幅下调了2025财年的全年指引。公司将全年收入预期从此前的2.68-2.75亿美元下调至2.50-2.55亿美元，远低于分析师预期的2.704亿美元。公司表示，这主要是由于其Rex MD业务面临一些暂时性挑战。尽管如此，LifeMD仍强调了一些积极发展，包括活跃远程医疗用户增长16%至约297,000人，以及调整后EBITDA的显著提升。然而，这些亮点似乎未能抵消投资者对业绩不及预期和下调指引的担忧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.